Hepatitis Virus C NS3 Protease Inhibitor 2
≥98%
- Product Code: 100807
CAS:
208939-95-1
| Molecular Weight: | 913.10 g./mol | Molecular Formula: | C₄₃H₅₆N₆O₁₄S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
This compound is primarily utilized in the development of antiviral therapies targeting Hepatitis C Virus (HCV). It functions as a potent inhibitor of the NS3 protease, an enzyme crucial for viral replication. By blocking this enzyme, the compound effectively halts the virus's ability to reproduce, thereby reducing viral load in infected individuals. Its application is significant in the formulation of direct-acting antiviral (DAA) drugs, which are a cornerstone in modern HCV treatment regimens. The compound contributes to improved efficacy, shorter treatment durations, and reduced side effects compared to traditional therapies. Ongoing research also explores its potential in combination therapies to enhance treatment outcomes and combat drug-resistant strains of HCV.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿45,000.00 |
+
-
|
Hepatitis Virus C NS3 Protease Inhibitor 2
This compound is primarily utilized in the development of antiviral therapies targeting Hepatitis C Virus (HCV). It functions as a potent inhibitor of the NS3 protease, an enzyme crucial for viral replication. By blocking this enzyme, the compound effectively halts the virus's ability to reproduce, thereby reducing viral load in infected individuals. Its application is significant in the formulation of direct-acting antiviral (DAA) drugs, which are a cornerstone in modern HCV treatment regimens. The compound contributes to improved efficacy, shorter treatment durations, and reduced side effects compared to traditional therapies. Ongoing research also explores its potential in combination therapies to enhance treatment outcomes and combat drug-resistant strains of HCV.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :